Post-Approval Study of the Neuspera Sacral Neuromodulation System

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.
Epistemonikos ID: eb584485658e6d47a15e8df995675a308b727523
First added on: Aug 29, 2025